1,165 results on '"Battistella, Maxime"'
Search Results
2. Indeterminate DC histiocytosis is distinct from LCH and often associated with other hematopoietic neoplasms
3. Radiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour group
4. Wnt/β-Catenin–Activated Nonpilomatrical Carcinoma of the Skin: A Case Series
5. Hidrocystoma-like tumours with RET or ALK fusion: a study of four cases
6. Pathophysiology of cutaneous T-cell lymphomas: Perspective from a French referral centre
7. Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study
8. From Histiocytoid Sweet Syndrome to Myelodysplasia Cutis: History and Perspectives
9. SOX10-Internal Tandem Duplications and PLAG1 or HMGA2 Fusions Segregate Eccrine-Type and Apocrine-Type Cutaneous Mixed Tumors
10. Re-evaluation of the concept of basaloid follicular hamartoma associated with naevoid basal cell carcinoma syndrome: a morphological, immunohistochemical and molecular study
11. Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study
12. IgA vasculitis with underlying monoclonal IgA gammopathy: innovative therapeutic approach targeting plasma cells. A case series
13. Sweat Gland Tumors Arising on Acral Sites: A Molecular Survey
14. Digital Papillary Adenocarcinoma in Nonacral Skin: Clinicopathologic and Genetic Characterization of 5 Cases
15. Genomic profiling of a skin adnexal carcinomas cohort using a comprehensive high throughput sequencing approach
16. Tumeurs annexielles cutanées : mise au point et synthèse des gènes de fusion à connaître pour le diagnostic
17. Graft-versus-lymphoma effect in skin after allogeneic hematopoietic stem cell transplantation for Sézary syndrome
18. A massive open online course to teach undergraduate medical students in oncology: keys of success
19. Novel treatment strategy for NRAS-mutated melanoma through a selective inhibitor of CD147/VEGFR-2 interaction
20. PD-1 blockade with pembrolizumab in classic or endemic Kaposi's sarcoma: a multicentre, single-arm, phase 2 study
21. Macrophage-derived CXCL9 and CXCL11, T-cell skin homing, and disease control in mogamulizumab-treated CTCL patients
22. Metastatic perirectal PEComa treated by checkpoint inhibitor immunotherapy and multimodal treatment: case report and review of the literature.
23. Lymphocytic Thrombophilic Arteritis (Macular Lymphocytic Arteritis)
24. Clinicopathologic and molecular characterization of melanomas mutated for CTNNB1 and MAPK
25. Porocarcinomas with PAK1/2/3 fusions: a series of 12 cases
26. Nuclear pseudoinclusions as a clue for NUTM1‐rearranged poroid tumours recognition
27. Cutaneous clonal mature plasmacytoid dendritic cell dermatosis in patients with myeloid neoplasms
28. An Indolent Forearm Plaque: A Quiz
29. Line‐field confocal optical coherence tomography in vivo description of Sarcoptes scabiei and histological correlation
30. Impact of blood tumour clone frequency on time to next treatment in mycosis fungoides
31. Targeting TGF-beta activation in cutaneous T-cell lymphomas
32. Periorbital erythema and oedema revealing angioimmunoblastic T cell lymphoma
33. Impact des algorithmes du groupe français d’étude des lymphomes cutanés (GFELC) sur le diagnostic anatomopathologique des lymphoproliférations cutanées
34. A Multicenter Phase II Study of Pazopanib in Patients with Unresectable Dermatofibrosarcoma Protuberans
35. Hidrocystoma-like tumours with RETor ALKfusion: a study of four cases
36. Exploring the molecular landscape of cutaneous mixed tumors characterized by TRPS1::PLAG1 gene fusion.
37. Citrullinated Histone H3, a Marker for Neutrophil Extracellular Traps, Is Associated with Poor Prognosis in Cutaneous Squamous Cell Carcinoma Developing in Patients with Recessive Dystrophic Epidermolysis Bullosa.
38. Sezary syndrome revealed by PD‐L1 blockade for tumor stage mycosis fungoides.
39. A Sub-Group of Kidney-Transplant Recipients with Highly Aggressive Squamous Cell Carcinoma Expressing Phosphorylated Serine392p53
40. CD39 is expressed by a wide range of cutaneous T‐cell lymphomas
41. Erratum to ‘Molecular profiling of anal Paget’s disease and underlying anal adenocarcinoma highlights their common origin’ [EJC Skin Cancer 1 (2023) 100002]
42. Two cases of Dupilumab responsive Kimura disease
43. Letter to the Editor re: Observational study investigating the level of support from a convolutional neural network in face and scalp lesions deemed diagnostically ‘unclear’ by dermatologists
44. Transcriptomic Landscape of Prurigo Nodularis Lesional Skin CD3+ T Cells Using Single-Cell RNA Sequencing
45. CD30-positive anaplastic large-cell lymphoma associated with mycosis fungoides after treatment with dupilumab
46. A Melanoma-Tailored Next-Generation Sequencing Panel Coupled with a Comprehensive Analysis to Improve Routine Melanoma Genotyping
47. Neutrophilic Dermatoses in Blood Disorders
48. Targeting TGF-β Activation in Cutaneous T-Cell Lymphomas
49. IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial
50. Pédagogie à grande échelle en ACP
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.